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Abstract
Introduction—Prader-Willi syndrome (PWS) is a complex genetic disorder associated with three 
different genetic subtypes: deletion of the paternal copy of 15q11-q13, maternal uniparental 
disomy (UPD) for chromosome 15, and imprinting defect (ID). Patients are typically diagnosed 
because of neonatal hypotonia, dysmorphism and feeding difficulties, however data of the prenatal 
features of PWS are limited.
Objective—The aim of the study was to identify and compare frequencies of prenatal and 
neonatal clinical features of PWS amongst the three genetic subtypes.
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Methods—Data from 355 PWS patients from the Rare Diseases Clinical Research Network 
(RDCRN) PWS registry was used to analyze multiple maternal and neonatal factors collected 
during an eight-year multi-site study.
Results—Amongst our cohort of 355 PWS patients (61% deletion, 36% UPD and 3% IC defect) 
54% were born by Cesarean section, 26% were born prematurely and 34% with a low birth-weight 
(frequencies 32%, 9.6% and 8.07% respectively in the general population). Fetal movements were 
reported as decreased in 72%. All babies were hypotonic, and 99% had feeding difficulties. Low 
Apgar scores (< 7) were noted in 17.7% and 5.6% of patients respectively compared to 1% and 
1.4% respectively in the general population. Maternal age and pre-pregnancy weight were 
significantly higher in the UPD group (p value 0.01, <0.001 respectively).
Conclusion—We found a higher rate of perinatal complications in PWS syndrome compared to 
the general population. No significant differences in the genetic subtypes were noted except for a 
higher maternal age and pre-pregnancy weight in the UPD subgroup
INTRODUCTION
Lack of expression of genes on the paternally inherited chromosome 15q11-q13 region 
causes Prader-Willi syndrome (PWS).1 This complex neurobehavioral condition affects 
about 1 in 10,000–15,000 live births.2 Most patients with PWS have a paternal deletion of 
15q11-q13 (70%), approximately 25–30% have maternal uniparental disomy (UPD) 15 and 
1–3% have an imprinting defect (ID). Babies with PWS present with hypotonia, poor suck 
and feeding difficulties, dysmorphic features and hypogonadism. Later, obesity and 
hyperphagia results if caloric intake is not controlled.3,4,5 These findings may be subtle in 
the immediate newborn period or may be masked by prematurity and other neonatal 
complications.6,7,8
Perinatal features of PWS reported in the literature include decreased fetal movements, 
polyhydramnios, malpresentation, and fetal heart rate abnormalities.6,9–13 These obstetric 
complications frequently result in assisted vaginal deliveries with forceps or vacuum and 
Cesarean sections. Perinatal features have been described in the literature as clinical reports 
or small case series. In this study, we aimed to characterize these findings in a large well-
studied cohort of 355 subjects enrolled in the NIH Rare Disease Clinical Research Network 
(RDCRN) PWS registry with special emphasis on natural history and genotype-phenotype 
correlations. The goal of this study was to provide an accurate incidence of the maternal and 
neonatal features of PWS. We believe that increased awareness among obstetricians and 
health care providers would allow earlier diagnosis and treatment of PWS by pediatricians/
neonatologists with subsequent reduction of morbid obesity and other comorbidities 
impacting on quality of life
METHODS
We analyzed de-identified data from 355 PWS patients from the RDCRN PWS registry. The 
registry patients were enrolled by PWS experts following signed consent of IRB approved 
forms at four different clinical sites: University of California, Irvine, CA; Kansas University 
Medical Center, Kansas City, KS; Vanderbilt University, Nashville, TN and University of 
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Florida, Gainesville, FL. All data from this registry were managed by the Data Management 
Coordinating Center in Tampa, FL (DMCC). The DMCC facilitated the generation of 
electronic forms for data entry, data retrieval, and statistical analyses. Our multicenter 
longitudinal observational natural history study was supported by the NIH. We analyzed data 
on maternal and neonatal features collected through standardized natural history 
questionnaires completed by the registry team and compared variables to the existing 
general population with their PWS genetic subtypes (Table 1).
STATISTICS
The categorical variables were summarized using frequencies and continuous variables with 
calculated average ± SD scores. Pearson Chi-square test was used to compare categorical 
variables and student t-test for comparison of continuous variables. Fisher’s exact test was 
used to compare categorical variables when the expected cell count was less than 5. SPSS 20 
software (Armonk, NY) was used for statistical analysis and p-values less than 0.05 were 
considered statistically significant.
RESULTS
The descriptive statistics of maternal and neonatal outcome variables are summarized in 
Table 2. Out of 355 PWS patients enrolled in the registry, 217 patients had the 15q11-q13 
deletion (61%); of these 98 were males (45.2%) and 119 females (54.8%); 127 patients had 
maternal UPD (36%) comprising of 52 males (40.9%) and 75 females (59.1%), and 11 had 
imprinting defects (3%), this group was comprised of 8 males (72.7%) and 3 females 
(27.3%).
Seventy-eight percent of PWS mothers reported decreased fetal movements during their 
pregnancy and 99.7% of the babies had hypotonia postnatally. Fifty-five percent of PWS 
babies were born by Cesarean section, significantly higher than the Cesarean section rate of 
32% for all deliveries in the United States as reported in 2017 by the CDC14 (Table 2).
We also found a higher incidence of low birth weight babies (34%) in our study group 
compared with 8.1% incidence of low birth babies in the United States (CDC 2017)14 (Table 
2). We found 5% (16/322) from our individuals had a very low birth weight (<1500 g). The 
5% incidence of very low birth weight babies in this PWS group is approximately three 
times higher than the 1.4% for the overall incidence of extremely low birth weight infants in 
the United States14 (Table 2).
Ninety-nine percent of babies with PWS had difficulty feeding (Table 2) and 75% needed 
supplementation with feeding tube (Table 2). Among the babies with PWS who needed help 
with a feeding tube, 25% required invasive gastrostomy tube placement and 75% needed a 
nasogastric or orogastric tube (Table 2). Only 22% of the babies were breastfed in our study 
population.
We found that PWS babies were born to mothers with a mean age of 31.4 (range 16 to 47) 
years, a mean pre-pregnancy weight of 63.8 kg and a mean weight gain of 13.9 kg during 
pregnancy. Eighteen percent of mothers reported polyhydramnios during the pregnancy and 
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5% had oligohydramnios. Four percent of mothers had gestational diabetes, 6% with high 
blood pressures during pregnancy but only 1% had pre-eclampsia. Eight percent of mothers 
reported premature rupture of membranes, 4% had an abnormal placenta (4 had abnormal 
placental location (3 placenta previa and 1 with low-lying placenta), three had placental 
insufficiency, two had calcified placentae, one had a post mature placenta, two had abruptio 
placenta, one had a thickened placenta, and two had unspecified placental abnormalities. 
Gestational age at birth ranged from 25 to 44 weeks with a mean of 37.9 weeks and 25% of 
the babies were born prematurely (<37 weeks). Mean Apgar scores were 6.5 at 1 minute and 
8 at 5 minutes. Babies with PWS had a range of birth length from 17 to 60 cm (mean of 48.7 
cm) and head circumference of 25 to 42 cm (mean of 34.2 cm). A weak cry was noted in 
95%, hypotonia in 99.7% and feeding difficulty in 99% the most consistent clinical features 
in our study. Although most of these babies suffered from failure to thrive (77%) and several 
with gastroesophageal reflux disease (24%), about 5% were overweight before their first 
birthday (Table 2).
Comparison of the Variables by Genetic Subtype
We compared all maternal and neonatal outcome variables by their PWS genetic subtype 
(Deletion, UPD or IC defect). No significant differences were found in incidence of maternal 
complications across the three genetic subtypes except for a significant difference in the 
mother’s pre-pregnancy weight (p=0.01) and maternal age (p < 0.0001) with an increased 
weight and age noted in the mothers of those babies with UPD. There was no difference in 
the neonatal outcomes in the three genetic subtypes (Table 3).
We also combined the UPD and IC defects and compared the frequency of the factors to the 
15q11-q13 deletion group. Mother’s weight before pregnancy (p=0.015) and the maternal 
age (p<0.0001) continued to be significantly different between the two genetic subtype 
groups. Patients from the combined UPD and IC defect group were born to mothers who 
were older (34.8 years vs. 29.2 years) and had a higher mean pre-pregnancy weight (66.2 kg 
vs. 62.3 kg), indicating that advanced maternal age and pre-pregnancy overweight/obesity 
increases the risk particularly for the UPD group. Additionally, a weak cry was noted to be 
slightly more frequent in the deletion subtype (97%) babies compared to in the combined 
group (92%, p=0.048). All of the other maternal and neonatal outcome variables showed no 
differences between the deletion and combined UPD and IC defect subtypes.
DISCUSSION
Prader, Labhart and Willi first recognized and described the Prader-Willi syndrome in 
195627. Holm et al. (1981) later established the PWS clinical diagnostic criteria which was 
revised in 199328,29 and again in 2001 due to significant advances in genetic testing and 
assessments.18 Gillessen-Kaesbachet et al. (1995) showed that babies with PWS from 
Germany due to UPD had a significantly higher birth weight; however, Gunay-Aygun et al. 
(1997) showed that the reverse was true in babies from the United States. Varela et al. (2005) 
found no statistically significant difference regarding these parameters in babies with PWS 
from Brazil.30–33 In term infants the incidence of low birth weight was higher in our PWS 
cohort group (34%) versus the population rate of 8.1 % in United States.14 In our study 
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however, we did not find any significant difference in birth weight, length or head 
circumference in babies by PWS genetic subtype.
Whittington et al. (2008)10 reported perinatal features of PWS in 46 UK babies, which was 
similar to the present study where we found a significant difference between the PWS 
genetic subtypes for mother's age and birth weight. In our study we also found a similar 
correlation between UPD and maternal age (35.2 years for UPD vs. 29.1 years for the 
deletion group) but we did not find any difference in birth weight10. Dudley et al. (2007) 
reported a significantly higher rate of miscarriage, polyhydramnios (27%), induced labor, 
Cesarean section (53%), low birth weight (37%), hypotonia (97%) and poor nippling (83%) 
in a French population of PWS. They also found significant differences between PWS 
genetic subtypes for higher rate of induced labor (79% vs. 48%), prematurity (26% vs. 8%) 
and older maternal age in UPD (36.4 years vs. 29.3 years) and lower birth weight for 
newborns with deletion, concluding a significant antenatal complication rate associated with 
UPD but more significant weight abnormalities associated with the deletion subtype of 
PWS.11 Our study confirms similar rates of Cesarean section (55%), hypotonia (99.7%), and 
low birth weight (34%), but showed a lower risk for polyhydramnios (18%) and a higher risk 
for feeding difficulty (99%) as in previous studies. Our study also confirms that patients with 
UPD are born to older mothers with higher pre-pregnancy weights compared to patients with 
the 15q11-q13 deletion lending support to non-disjunction associated trisomy rescue in in 
the etiology of PWS UPD; the rates of prematurity and low birth weight however were 
found to be similar by genetic subtype in our study population. Hiroi et. al. (2000)34 
described abnormal ultradian heart rhythm of fetuses with PWS, which could be an early 
sign of PWS. Abnormal heart rate or rhythm may increase the risk for preterm induction of 
labor and emergency delivery by Cesarean section. Our study did not look at incidence of 
abnormal heart rate but our study had significantly higher rate of Cesarean deliveries 
compared to the general population per CDC statistics (54% vs. 32%).14
High Cesarean section rates can be associated with PWS perinatal complications like 
polyhydramnios, decreased fetal movements, and abnormal heart rate/rhythm. 
Polyhydramnios is seen in about 1–3% of pregnancies which could be a sign of underlying 
maternal or fetal disease and contribute significantly to perinatal morbidity and mortality in 
both mothers and babies.16 A recently published retrospective matched case control study by 
Suleiman et al. (2017) found polyhydramnios to be an independent risk factor for a Cesarean 
delivery.35 Our study found 18% of PWS patients had polyhydramnios prenatally which is 
significantly higher than the general population. Decreased fetal movements were added as 
one of the minor diagnostic criteria by Holm et al (1993). Decreased fetal movements were 
also seen in 78% of our study population which is similar to previous reports.10,11,1736,
In summary, our study reported the incidence of perinatal features in a large cohort of 
individuals with PWS. We found a high incidence of decreased fetal movements and 
delivery by Cesarean section compared to the general population. Babies with PWS were 
also found to be at a high risk for low birth weight (< 2500 g) in babies delivered at term 
(34%) and preterm (<37 weeks) (38.2%). Hypotonia, a weak cry and feeding difficulties 
were the most consistent clinical features of PWS in the newborn period. Most of the babies 
with feeding difficulties required assistance and the use of a feeding tube with 25% requiring 
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gastrostomy tube placement. There were no significant intergenetic PWS subtype 
differences except for maternal age and pre-pregnancy maternal weight being significantly 
higher in the UPD group supporting meiotic non-disjunction and associated trisomy rescue 
events in early pregnancy.
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Table 1
Maternal and neonatal variables analyzed in the study
Maternal Variables Neonatal Variables
1 Maternal age
2 Mother’s weight before pregnancy
3 Maternal weight gain during pregnancy
4 Maternal body mass index (BMI)
5 Assessment of fetal movements
6 Mode of delivery
7 Polyhydramnios
8 Oligohydramnios
9 Gestational diabetes
10 Preterm labor
11 High blood pressure
12 Pre-eclampsia
13 Premature rupture of membranes
14 Abnormal placenta
1 PWS genetic subtype
2 Gestational age
3 Birth weight
4 Birth length
5 Birth head circumference
6 Apgar score at 1 minute
7 Apgar score at 5 minutes
8 Failure to thrive
9 Breastfeeding
10 Feeding difficulty
11 Gastro-esophageal reflux disease
12 Use of feeding tube
13 Type of feeding tube
14 Weak cry
15 Hypotonia
16 Overweight before 1 year of age
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Table 2
Descriptive statistics of maternal and neonatal outcome variables in Prader- Willi syndrome.
Maternal and Neonatal
Outcomes
Study Statistics Population
Statistics
Maternal age 16–47 years, mean 31.4 years 26.4 years14
Maternal body mass index (BMI) (mean ± SD) 26.5 ± 6 25.6% have BMI 25–29.915
Assessment of fetal movements (N=328) Decreased - 256 (78%) NA
Normal - 67 (20%)
Increased - 5 (2%)
Mode of delivery (N=348) Cesarean section - 190 (54.6%) 32%14
Vaginal - 158/348 (45.4%)
Polyhydramnios 62 (18%) 1–3%16,17
Oligohydramnios 18 (5%) 11%18
Gestational diabetes 14 (4%) 9%19
High blood pressure 20 (6%) 9%20
Pre-eclampsia 5 (1%) 3.4%21
Premature rupture of membranes 30 (8%) Term-8%, Preterm-3%22
Prader-Willi syndrome genetic subtypes (N=355), 
(M=Males, F=Females)
Deletion 15q11-q13 - 217 (61%) (M/F 98/119, 
45.1%/ 54.8%)
Deletion 15q11-q13 −70%
Maternal disomy 15– 25%
Maternal uniparental disomy 15–127(36%) (M/F 
52/75, 40.9%/59%)
Imprinting defect - 2–5%
Imprinting defect 11 (3%) (M/F 8/3; 72.7%/ 
27.2%)
Gestational age in weeks (N=343)
Preterm (<37 weeks) 90 (26%) 9.6%14
Term (37–41.6 weeks) 227 (66%) 83.4%14
Post-term (>42 weeks) 26 (8%) 0.4%14
Birth weight (N=322) (mean, range) 2713 g (703 – 5000 g)
Normal birth weight (>2500 g) 212 (66%) 90.6%14
Low birth weight (<2500 g) 110 (34%) 8.1%14
Very low birth weight (<1500 g). 16 (5%) 1.4%14
Birth length (mean ± SD) 48.8 ± 5.8 cm for boys 45.9–54.8 cm for boys23
48.4 ± 3.9 cm for girls 45.9–54 cm for girls23
Birth head circumference (mean ± SD) 34.5 ± 3.4 cm for boys/33.8 ± 3.2 cm for girls 32.1–38.6 cm for boys23
32.3–37.8 cm for girls23
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Maternal and Neonatal
Outcomes
Study Statistics Population
Statistics
Apgar score at 1 minute (mean) 6.5 ± 2.27 Low Apgar score in 1 %
Low Apgar score <7 17.7%
Apgar score at 5 minutes (mean) 8.0 ± 1.7 Low Apgar score in 1.4%24
Low Apgar score <7 5.6%
Failure to thrive (N=343) 263 (77%) 5–10%25
Breastfeeding (N=343) Yes With difficulty/without 
difficulty
76 (22%) (96%, 4%) 83%26
Feeding difficulty (N=344), (Severe, Moderate, Mild) 340 (99%) (68%, 26%, 5%) NA
Use of feeding tube (N=339) Yes - 254 (75%) No - 85 (25%) NA
Feeding tube type (N=236)
Gavage (NG/OG) 177 (75%) NA
Gastrostomy tube 59 (25%)
Weak cry 328/344 (95%) NA
Hypotonia (N=340) 339 (99.7%) NA
J Med Genet. Author manuscript; available in PMC 2019 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Singh et al. Page 12
Table 3
Maternal and Neonatal outcomes by Prader- Willi syndrome genetic subtype (Deletion vs. UPD - Uniparental 
Disomy, vs ICD - Imprinting Defect).
Maternal Outcome Deletion (217) UPD (127) ICD (11) p-value
Maternal age (mean ± SD) 29.2 years ± 5.3 35.2 years ± 6.1 30.8 years ± 4.77 <0.001
Mother’s weight before pregnancy (mean ± SD) 62.3 kg ± 12.9 66.6 kg ± 15.4 61.9 kg ± 8.1 0.01
Maternal weight gain during pregnancy (mean ± SD) 14.2 kg ± 6.6 13.56 kg ± 5.7 13.3 kg ± 6.9 0.36
Maternal body mass index (mean ± SD) 26 ± 5.7 27.1 ± 6.2 28 ± 8.3 0.16
Decreased fetal movements 161/209 (77%) 88/124 (71%) 7/11 (64%) 0.33
Cesarean section 120/211 (57%) 66/126 (52%) 4/11 (36%) 0.40
Polyhydramnios 33 (15%) 28 (22%) 1 (9%) 0.21
Oligohydramnios 12 (55%) 6 (5%) 0 0.70
Gestational diabetes 9 (4%) 5 (4%) 0 0.79
Preterm labor 56 (26%) 34 (27%) 0 0.13
High blood pressure 10 (5%) 9 (7%) 1 (9%) 0.56
Pre-eclampsia 3 (1%) 2 (2%) 0 0.91
Premature rupture of membranes 20 (9%) 9 (7%) 1 (9%) 0.79
Abnormal placenta 8 (4%) 7 (6%) 0 0.56
Neonatal Outcome
Mean birth weight (>37 weeks) ±SD 2752 ± 0.58 2591± 0.67 2857 ± 0.39 0.13
Mean birth weight (<37 weeks) ±SD 2165 ± 0.61 2091± 0.51 2200 ± 0.40 0.12
Low birth weight (<2500 g) >37weeks 46/142 (32%) 32/78 (41%) 1/10 (10%) 0.23
Birth length (mean ± SD) cm. 48.9 ± 3.9 47.8 ± 6.5 51.4 ± 4.5 0.09
Birth head circumference (mean ± SD)cm. 34.8 ± 3.3 33.4 ± 3.2 35.2 ± 2.02 0.11
Apgar score at 1 min (mean ± SD) 6.4 ± 2.2 6.6 ± 2.3 6.6 ± 2.3 0.77
Apgar score at 5 min (mean ± SD) 7.9 ±1.7 8.0 ± 1.8 7.6 ± 1.6 0.86
Failure to thrive 166 (76%) 89 (70%) 8 (73%) 0.23
Breastfeeding 43 (20%) 28 (22%) 5 (45%) 0.15
Feeding difficulty 207 (95%) 122 (96%) 11 (100%) 0.81
Gastroesophageal reflux disease 53 (24%) 31 (24%) 1 (9%) 0.33
Feeding tube used 151/203 (74%) 95/125 (76%) 8/11 (73%) 0.58
Gastrostomy tube 39/151 (26%) 19/95 (20%) 5/8 (63%) 0.25
Weak cry 204 (94%) 113 (89%) 11 (100%) 0.07
Hypotonia 206/207 (99.5%) 122/122 (100%) 11/11 (100%) 0.87
Overweight before 1 year of age 7 (3%) 9 (7%) 1 (9%) 0.23
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